Genesis Healthcare Inc. buy Wells Fargo & Company
Start price
08.08.25
/
50%
€0.38
Target price
08.08.26
€34.30
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 08.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Genesis Healthcare Inc. | - | - |
| iShares Core DAX® | 1.085% | -1.655% |
| iShares Nasdaq 100 | -1.665% | -3.137% |
| iShares Nikkei 225® | 3.863% | 6.947% |
| iShares S&P 500 | 0.111% | -1.320% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Genesis Healthcare Inc. diskutieren
Gen Digital Inc. (NASDAQ: GEN) had its price target raised by analysts at Wells Fargo & Company from $37.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for GEN provided by MarketBeat